UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Anthracycline Chemotherapy and Cardiotoxicity.

McGowan, JV; Chung, R; Maulik, A; Piotrowska, I; Walker, JM; Yellon, DM; (2017) Anthracycline Chemotherapy and Cardiotoxicity. Cardiovascular Drugs and Therapy , 31 (1) pp. 63-75. 10.1007/s10557-016-6711-0. Green open access

[thumbnail of art%3A10.1007%2Fs10557-016-6711-0.pdf]
Preview
Text
art%3A10.1007%2Fs10557-016-6711-0.pdf - Published Version

Download (631kB) | Preview

Abstract

Anthracycline chemotherapy maintains a prominent role in treating many forms of cancer. Cardiotoxic side effects limit their dosing and improved cancer outcomes expose the cancer survivor to increased cardiovascular morbidity and mortality. The basic mechanisms of cardiotoxicity may involve direct pathways for reactive oxygen species generation and topoisomerase 2 as well as other indirect pathways. Cardioprotective treatments are few and those that have been examined include renin angiotensin system blockade, beta blockers, or the iron chelator dexrazoxane. New treatments exploiting the ErbB or other novel pro-survival pathways, such as conditioning, are on the cardioprotection horizon. Even in the forthcoming era of targeted cancer therapies, the substantial proportion of today's anthracycline-treated cancer patients may become tomorrow's cardiac patient.

Type: Article
Title: Anthracycline Chemotherapy and Cardiotoxicity.
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s10557-016-6711-0
Publisher version: http://dx.doi.org/10.1007/s10557-016-6711-0
Language: English
Additional information: © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Cancer anthracycline doxorubicin chemotherapy cardiotoxicity cardioprotection
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science
URI: https://discovery.ucl.ac.uk/id/eprint/1542954
Downloads since deposit
77Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item